Drug Fail | GenomeWeb

Drug Fail

The failure rate for the approval of new drugs is bad, everyone knows that. But it may be worse than most everyone thought, writes Derek Lowe, who summarizes the latest data on drug success rates in the blog Corante.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Targeted to More

Where Harvard Lags

This Week in PLOS

Review of Peer Review

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.